Richard Glickman

Business address
C/O Aspreva Pharmaceuticals Corporation, 1203 4464 Markham Street, Victoria, British Columbia, Canada, V8Z7X8
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Richard Glickman has filed 15 SEC EDGAR filings since 2/14/2006

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT Oct 15, 2025 Oct 9, 2025 001-37410
4 Open Document Open Filing Jun 16, 2025 Jun 16, 2025 001-41854
4 Open Document Open Filing Jun 18, 2024 Jun 15, 2024 001-41854
4 Open Document Open Filing May 29, 2024 May 28, 2024 001-41854
4 Open Document Open Filing Apr 25, 2024 Apr 24, 2024 001-37410
4 Open Document Open Filing Mar 28, 2024 Mar 25, 2024 001-37410
4 Open Document Open Filing Nov 2, 2023 Oct 31, 2023 001-41854
3 Open Document Open Filing Oct 31, 2023 Oct 31, 2023 001-41854
4 Open Document Open Filing FORM 4 SUBMISSION Nov 1, 2022 Jun 29, 2022 001-37410
4/A Open Document Open Filing FORM 4/A SUBMISSION Jan 26, 2021 Dec 11, 2020 001-37410
4 Open Document Open Filing FORM 4 SUBMISSION Jan 11, 2021 Dec 11, 2020 001-37410
3 Open Document Open Filing FORM 3 SUBMISSION Oct 1, 2020 Oct 1, 2020 001-37410
SC 13D Open Document Open Filing SCHEDULE 13D Jan 25, 2016